Avoro Capital Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,275,000
Closed -$55.1M 41
2022
Q1
$55.1M Buy
2,275,000
+75,000
+3% +$1.82M 1.01% 19
2021
Q4
$51.3M Hold
2,200,000
0.87% 19
2021
Q3
$36.5M Sell
2,200,000
-241,658
-10% -$4.01M 0.57% 27
2021
Q2
$59.6M Sell
2,441,658
-58,342
-2% -$1.42M 1.04% 22
2021
Q1
$64.5M Buy
2,500,000
+550,000
+28% +$14.2M 1.11% 20
2020
Q4
$104M Buy
+1,950,000
New +$104M 1.8% 16
2020
Q2
Sell
-145,000
Closed -$6.13M 45
2020
Q1
$6.13M Buy
+145,000
New +$6.13M 0.21% 40
2019
Q4
Sell
-887,500
Closed -$31.9M 30
2019
Q3
$31.9M Sell
887,500
-437,500
-33% -$15.7M 1.33% 18
2019
Q2
$35.4M Hold
1,325,000
1.22% 19
2019
Q1
$35.6M Buy
+1,325,000
New +$35.6M 1.54% 19
2018
Q4
Sell
-100,000
Closed -$2.08M 34
2018
Q3
$2.08M Buy
+100,000
New +$2.08M 0.1% 39
2018
Q2
Sell
-317,100
Closed -$7.13M 42
2018
Q1
$7.13M Buy
+317,100
New +$7.13M 0.34% 36
2017
Q3
Sell
-614,200
Closed -$17.1M 40
2017
Q2
$17.1M Sell
614,200
-1,015,800
-62% -$28.3M 2.16% 14
2017
Q1
$56M Buy
1,630,000
+143,540
+10% +$4.93M 7.16% 4
2016
Q4
$42.9M Buy
1,486,460
+693,961
+88% +$20M 8.66% 1
2016
Q3
$25.2M Buy
792,499
+462,999
+141% +$14.7M 4.42% 8
2016
Q2
$10.7M Buy
+329,500
New +$10.7M 2.38% 15
2015
Q4
Sell
-581,900
Closed -$19.2M 29
2015
Q3
$19.2M Buy
581,900
+86,900
+18% +$2.87M 5% 6
2015
Q2
$20.7M Buy
+495,000
New +$20.7M 5.71% 6